Inhibitors against Lysine/DAP pathway of Mycobacterium tuberculosis

Article View: bionet.software

Article #2347

#2347

From: Raghava
Date: Tue, 19 Jan 2010 16:49

38 lines
5127 bytes

Dear Friends,
Recently, we have screened inhibitors against Mycobacterium
tuberculosis. List of inhibitors and our strategy of screening
inhibitors have been described in a paper published this week in BMC
Bioinformatics. Here, I am providing link of this paper and other
papers published this week. I hope this information will be useful for
members.

Garg, A., Tewari, R.  and Raghava, G. P. S. (2010) Virtual Screening
of potential drug-like inhibitors against Lysine/DAP pathway of
Mycobacterium tuberculosis.  BMC Bioinformatics 11:S53 URL:
http://www.biomedcentral.com/1471-2105/11/S1/S53

Ansari, H. R., Flower, D.R. and Raghava, G. P. S. (2010) AntigenDB: An
immunoinformatics database of pathogen antigens.  Nucleic Acids Res.
38: D847-D853. URL: http://nar.oxfordjournals.org/cgi/content/short/38/suppl_1/D847

Lata, S., Mishra, N.K. and Raghava, G. P. S. (2010) AntiBP2: Improved
version of antibacterial peptide prediction. BMC Bioinformatics
11:S19: URL: http://www.biomedcentral.com/1471-2105/11/S1/S19

Mishra, N.K. and Raghava, G. P. S. (2010) Prediction of FAD
interacting residues in a protein from its primary sequence using
evolutionary information. BMC Bioinformatics 11:S48. URL:
http://www.biomedcentral.com/1471-2105/11/S1/S48


With Regards

Raghava

======================================================
# Dr G P S Raghava (FASc, FNASc), Head Bioinformatics Centre   #
# Institute of Microbial Technology, Sector-39A, Chandigarh, India  #
# Phone: +91-172-2690557, Fax: +91-172-2690632
#
# Eadd: http://www.imtech.res.in/raghava/   raghava@imtech.res.in #
#=====================================================

Technical Details

Message-ID: <mailman.58.1263919845.1025.bio-soft@net.bio.net>

Path:

arc1-ca.pugleaf.net!g2news1.google.com!news1.google.com!Xl.tags.giganews.com!border1.nntp.dca.giganews.com!nntp.giganews.com!local2.nntp.dca.giganews.com!news.giganews.com.POSTED!not-for-mail

Show Full Headers

Complete Article Headers

X-Google-Thread: 6710630482,4f8808ac39879e72,start
X-Google-Attributes: gid6710630482,public,usenet
X-Google-NewGroupId: yes
X-Google-Language: ENGLISH,ASCII-7-bit
Path: arc1-ca.pugleaf.net!g2news1.google.com!news1.google.com!Xl.tags.giganews.com!border1.nntp.dca.giganews.com!nntp.giganews.com!local2.nntp.dca.giganews.com!news.giganews.com.POSTED!not-for-mail
NNTP-Posting-Date: Tue, 19 Jan 2010 10:51:12 -0600
X-Envelope-From: news@google.com
DKIM-Signature: v=1; a=rsa-sha256; c=relaxed/relaxed; d=gmail.com; s=gamma;
 h=domainkey-signature:received:received:received
 :x-authentication-warning:to:path:from:newsgroups:subject:date
 :organization:lines:message-id:nntp-posting-host:mime-version
 :content-type:x-trace:x-complaints-to:nntp-posting-date
 :complaints-to:injection-info:user-agent:x-http-via:x-http-useragent;
 bh=Tn7vKhTAdrAgK2wNTbCeg4Lq/NtZ5MeDNzhrlT9w0lo=;
 b=FDmNPXVvBDfrgl51ya1TL1D9RJCxEEcsDzTYzN23EH+IGhp7rlprqW/SeXf95Dv5+e
 CaS97ZJ8oMlFaHaDZt0NilNbsLcSooMHhpive4zGjHacAsLNCs89zaMgCbBp2dCogcHd
 Ib/Tfq6bt0eoJrhWBOApZKqsauP/jLbgD1Nas=
DomainKey-Signature: a=rsa-sha1; c=nofws; d=gmail.com; s=gamma;
 h=x-authentication-warning:to:path:from:newsgroups:subject:date
 :organization:lines:message-id:nntp-posting-host:mime-version
 :content-type:x-trace:x-complaints-to:nntp-posting-date
 :complaints-to:injection-info:user-agent:x-http-via:x-http-useragent;
 b=Ot2XoN5ug1qIpI7K6SErjB7YLXycGGctqBu5/PoIUa/t6pNhFphIQh/32S7OkcS1Br
 lpzMbHnPb6Wx5s15DiFmq3XlILydeMd/sau2ADAEFKRxwAHaVt/OxL/mHEO0qxE7RG2/
 mP4x1uPHA4xFOkSJMDRnRT0e42BeUVLJ0mqlI=
X-Authentication-Warning: yws13.prod.google.com: news set sender to
 news@google.com using -f
To: bionet-software@moderators.isc.org
From: Raghava <raghavagps@gmail.com>
Date: Tue, 19 Jan 2010 08:49:00 -0800 (PST)
Organization: http://groups.google.com
Mime-Version: 1.0
Content-Type: text/plain; charset=ISO-8859-1
Complaints-To: groups-abuse@google.com
Injection-Info: e16g2000yqc.googlegroups.com; posting-host=125.19.68.200; 
 posting-account=k9IIywoAAABrMwb9ubDn3NVZmHQYF5lJ
User-Agent: G2/1.0
X-HTTP-Via: 1.1 h99s120.imt.in:8082 (squid/2.5.STABLE6)
X-HTTP-UserAgent: Mozilla/5.0 (Macintosh; U; Intel Mac OS X 10_4_11; en) 
 AppleWebKit/531.21.8 (KHTML, like Gecko) Version/4.0.4 Safari/531.21.10,
 gzip(gfe), gzip(gfe)
X-Mailman-Approved-At: Tue, 19 Jan 2010 11:50:43 -0500
X-BeenThere: bio-soft@net.bio.net
X-Mailman-Version: 2.1.4
Precedence: list
subject: Inhibitors against Lysine/DAP pathway of Mycobacterium tuberculosis
Newsgroups: bionet.software
Message-ID: <mailman.58.1263919845.1025.bio-soft@net.bio.net>
Approved: BIOSCI Approval Key <biosci-approval-key@net.bio.net>
X-Auth: PGPMoose V1.1 PGP bionet.software
 iQCVAwUBS1Xi5aCIqsWvyF5FAQE5JwQAtNgHwOGKtzz7zqxNJyg7UW1hG8JCxvJV
 1m9wfDTQaX2bIZImfkUz8TZ7l5rCYY6wges+et0L0w3gZoNBc+nmOJPD25Nuklhh
 LxgxeKuKnq7CACVn8TFj8VUtj2DY7HZ3VkYTQDfQE8O+wy/GG2SETsVowQMKgzpA
 8sujnLBhYrM= =N2Cp
Lines: 39
X-Usenet-Provider: http://www.giganews.com
X-Trace: sv3-VcFzJs5UZimW0Jy8c6xJbM7RjSrF/QbdetwUSyuukkJi/Pn9KEsmA7ywiDxxfKEm91ky4Ddc2POTEys!b5qD610if2bMLdHGKb/t8iCazbj/LFz5ew8gS5zvlDI+/h3/6glBhtZ8Nur23sOS6vjg42mOKYYD!eA==
X-Complaints-To: abuse@giganews.com
X-DMCA-Notifications: http://www.giganews.com/info/dmca.html
X-Abuse-and-DMCA-Info: Please be sure to forward a copy of ALL headers
X-Abuse-and-DMCA-Info: Otherwise we will be unable to process your complaint properly
X-Postfilter: 1.3.40